Algert Global LLC Maravai Lifesciences Holdings, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $38,957 - $49,423	2,999 Added 6.8%	47,113 $660,000
Q4 2022 Feb 13, 2023	SELL	$12.5 - $24.78 $350,500 - $694,831	-28,040 Reduced 38.86%	44,114 $631,000
Q3 2022 Nov 15, 2022	BUY	$20.6 - $30.37 $178,210 - $262,730	8,651 Added 13.62%	72,154 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $90,627 - $130,392	3,479 Added 5.8%	63,503 $1.8 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $745,516 - $1.25 Million	30,479 Added 103.16%	60,024 $2.12 Million

Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $740,425 - $971,860	21,155 Added 252.15%	29,545 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $308,752 - $508,601	8,390 New	8,390 $412,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.